Filtered By:
Vaccination: Varicella-Zoster Virus Vaccine
Countries: Australia Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 23 results found since Jan 2013.
An evaluation of influenza, pneumococcal and herpes zoster vaccination coverage in Australian aged care residents, 2018 to 2022
CONCLUSIONS: Our study showed local influenza vaccination policies and practices exist and influenza vaccination uptake was consistently high. Pneumococcal and herpes zoster vaccination uptake were lower. Quality improvement strategies that at least determine the status of those residents classified as unknown are required.PMID:37147271 | DOI:10.1016/j.idh.2023.03.005
Source: Herpes - May 5, 2023 Category: Infectious Diseases Authors: Noleen Bennett Brett Morris Michael J Malloy Lyn-Li Lim Eliza Watson Ann Bull Janet Sluggett Leon J Worth NISPAC Advisory Group Source Type: research
ATAGI Targeted Review 2022: Vaccination for prevention of herpes zoster in Australia
Commun Dis Intell (2018). 2023 Apr 27;47. doi: 10.33321/cdi.2023.47.21.ABSTRACTIn November 2016, herpes zoster (HZ) vaccination for older adults, using the live-attenuated zoster vaccine (Zostavax; ZVL) was added to the Australian National Immunisation Program (NIP) with the aim of reducing morbidity from HZ and its complications, particularly for people at increased risk. Prior to the program, there were on average 5.6 cases of HZ per 1,000 persons annually in Australia, with highest risk of disease in older and in immunocompromised people. The burden of complications of HZ, such as post-herpetic neuralgia (PHN), was also...
Source: Herpes - April 27, 2023 Category: Infectious Diseases Authors: Yuanfei Anny Huang Jean Li-Kim-Moy Sanjay Jayasinghe Clayton Chiu Kristine Macartney Bette Liu Penelope Burns Michelle Giles Nigel Crawford Source Type: research
Vaccine-preventable hospitalisations in adult mental health service users: a population study
CONCLUSIONS: MH service users have increased risk of hospitalisation for many vaccine-preventable conditions. This may be due to reduced vaccination rates, more severe illness requiring hospitalisation, greater exposure to infectious conditions or other factors. People living with mental illness should be prioritised in vaccination strategies.PMID:37016779 | DOI:10.1017/S0033291723000776
Source: Psychological Medicine - April 5, 2023 Category: Psychiatry Authors: Grant Sara Patrick Gould Jackie Curtis Wendy Chen Michael Lau Parashar Ramanuj David Currow Philip Burgess Source Type: research
Associations between severe and notifiable respiratory infections during the first trimester of pregnancy and congenital anomalies at birth: a register-based cohort study
CONCLUSION: This large population-based study found severe acute respiratory infection in first trimester of pregnancy was associated with a higher risk of selected major cardiovascular anomalies in babies. These findings support measures to prevent acute respiratory infections in pregnant women including through vaccination.PMID:36964492 | PMC:PMC10037767 | DOI:10.1186/s12884-023-05514-8
Source: Herpes - March 25, 2023 Category: Infectious Diseases Authors: Abrar A Chughtai Wen-Qiang He Bette Liu Source Type: research
Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia's spontaneous vaccine pharmacovigilance system, 2016-2020
CONCLUSIONS: Disseminated VZV is potentially life-threatening and occurs mostly in those with severe immunocompromise. Inadvertent administration of ZVL to immunocompromised individuals has occurred despite initial provider guidance and education. Multiple additional strategies to assist providers to identify contraindications have been implemented to prevent adverse outcomes.PMID:36707120 | DOI:10.1136/bmjopen-2022-067287
Source: Herpes - January 27, 2023 Category: Infectious Diseases Authors: Jean Li-Kim-Moy Anastasia Phillips Adelaide Morgan Catherine Glover Sanjay Jayasinghe Brynley P Hull Aditi Dey Frank H Beard Megan Hickie Kristine Macartney Source Type: research
Reduction in Herpes Zoster Antiviral Use Since the Introduction of the Live-Attenuated Zoster Vaccine on Australia's National Immunisation Program: A Population-Based Study from 1994 to 2019
CONCLUSION: The introduction of the live-attenuated HZ vaccine on Australia's formal national vaccination program was associated with a reduction in HZ antiviral prescription rates within the Australian population. The data suggest that the introduction of Shingrix, the non-live subunit zoster vaccine, may also be associated with a similar reduction in HZ antiviral prescriptions used to treat the immunocompromised, as well as the general population, given its accepted greater efficacy over Zostavax.PMID:36626109 | DOI:10.1007/s40121-022-00749-y
Source: Herpes - January 10, 2023 Category: Infectious Diseases Authors: Sachin Phakey Sophie L Rogers Anthony J Hall Lyndell L Lim Source Type: research
Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation
CONCLUSION: Multidisciplinary strategies are needed to improve access to vaccination, community knowledge, community engagement, and healthcare provider support to provide appropriate care to migrants and younger cardiac patients and reduce morbidity and mortality in this high-risk group.PMID:36379753 | DOI:10.1016/j.vaccine.2022.10.090
Source: Vaccine - November 15, 2022 Category: Allergy & Immunology Authors: Elizabeth Benedict Kpozehouen Timothy Tan Chandini Raina Macintyre Source Type: research
